New pill tested to slow Parkinson's progression
Disease control
Completed
This study tested a new oral medication, CVN424, to see if it could help control the symptoms of early Parkinson's disease in people not yet taking standard treatments. Over 12 weeks, 64 participants were randomly assigned to take either the drug or a placebo pill. The main goal …
Phase: PHASE2 • Sponsor: Cerevance Beta, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC